US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

Direxion Daily S&P Biotech Bull 3x Shares

156.24

+7.394.96%

Post-market: 156.240.00000.00%16:25 EDT

Volume:570.41K

Turnover:89.34M

Market Cap:503.79M

PE:- -

High:158.64

Open:153.69

Low:153.48

Close:148.85

52wk High:198.18

52wk Low:32.55

Shares:3.22M

Float Shares:3.22M

Volume Ratio:0.76

T/O Rate:17.69%

Dividend:1.34

Dividend Rate:0.86%

ROE:--

ROA:--

PB:--

PE(LYR):- -

Loading ...

Overview Company News Filings

Exclusive: AI's Next Boom? Health Care And Space, Says Fusion Fund's Lu Zhang

Benzinga_recent_news

Sagimet: Undervalued MASH and Acne Pipeline with Best-in-Class Combination Potential Supports Buy Rating

IotaMotion Strengthens Leadership Position in Robotic Cochlear Implant Surgery with Issuance of New U.S. Patent

Jefferies Remains a Buy on Regeneron (REGN)

Evercore ISI Remains a Buy on BioNTech SE (BNTX)

Jefferies Remains a Buy on Oruka Therapeutics (ORKA)

Clearmind advances recruitment for CMND-100 trial’s third cohort

Analysts Offer Insights on Healthcare Companies: Legend Biotech (LEGN) and Medtronic (MDT)

New Study Shows Adherence to Monthly Injectable Buprenorphine Linked to Lower Healthcare Utilization and Costs in Opioid Use Disorder

Aster DM Healthcare’s creditors clear key vote on amalgamation plan

Sonida Senior Living Closes Transformative CNL Healthcare Acquisition

Scotiabank Remains a Buy on American Healthcare REIT, Inc. (AHR)

Fidia Completes Bond Conversion, Expands Share Capital and Free Float

SCIENTURE Broadens Commercial Access for REZENOPY™, Highest-Dose FDA-Approved Naloxone Nasal Spray, Through GPO Agreements Reaching Over 5,000 U.S. Institutions

Huadong Medicine's Investigational Drug HDM2024 Receives FDA Clearance for US Clinical Trial

Analysts Have Conflicting Sentiments on These Healthcare Companies: Atricure (ATRC), Q32 Bio (QTTB) and Shoulder Innovations, Inc. (SI)

Analysts Conflicted on These Healthcare Names: MoonLake Immunotherapeutics (MLTX), Sarepta Therapeutics (SRPT) and vTv Therapeutics (VTVT)

Analysts’ Opinions Are Mixed on These Healthcare Stocks: Kairos Pharma, Ltd. (KAPA), Pfizer (PFE) and Medtronic (MDT)

Canaccord Genuity Reaffirms Their Buy Rating on BioNTech SE (BNTX)

Analysts’ Opinions Are Mixed on These Healthcare Stocks: Evotec AG (EVO), Shoulder Innovations, Inc. (SI) and Bausch + Lomb Corporation (BLCO)

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/stock/LABU/news?page=7"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"LABU","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"LABU\",,,,,undefined,":{"symbol":"LABU","market":"US","secType":"STK","nameCN":"Direxion Daily S&P Biotech Bull 3x Shares","latestPrice":156.24,"timestamp":1773691200000,"preClose":148.85,"halted":0,"volume":570413,"hourTrading":{"tag":"盘后","latestPrice":156.24,"preClose":156.24,"latestTime":"16:25 EDT","volume":652,"amount":101915.60004,"timestamp":1773692753612,"change":0,"changeRate":0,"amplitude":0.005739},"delay":0,"changeRate":0.049647295935505646,"floatShares":3224486,"shares":3224486,"eps":0,"marketStatus":"Post-Mkt","change":7.39,"latestTime":"03-16 16:27:06 EDT","open":153.69,"high":158.635,"low":153.48,"amount":89335631.2841,"amplitude":0.034632,"askPrice":156.8,"askSize":200,"bidPrice":155.2,"bidSize":200,"shortable":3,"etf":3,"ttmEps":0,"tradingStatus":3,"nextMarketStatus":{"tag":"Closed","tradingStatus":0,"beginTime":1773705600000},"marketStatusCode":4,"adr":0,"adrRate":0,"exchange":"ARCA","adjPreClose":148.85,"sharesOutstanding":3074486,"nav":149.06,"aum":480642683.13,"dividendRate":0.008574,"bidAskSpread":0.002274,"preHourTrading":{"tag":"盘前","latestPrice":154.01,"preClose":148.85,"latestTime":"09:29 EDT","volume":8503,"amount":1296187.45652,"timestamp":1773667794593,"change":5.16,"changeRate":0.034666,"amplitude":0.029627},"postHourTrading":{"tag":"盘后","latestPrice":156.24,"preClose":156.24,"latestTime":"16:25 EDT","volume":652,"amount":101915.60004,"timestamp":1773692753612,"change":0,"changeRate":0,"amplitude":0.005739},"volumeRatio":0.760543,"impliedVol":1.0565,"impliedVolPercentile":0.8924},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"LABU\",,,,,undefined,":{"symbol":"LABU","floatShares":3224486,"roa":"--","roe":"--","lyrEps":0,"volumeRatio":0.760543,"shares":3224486,"dividePrice":1.3396,"high":158.635,"amplitude":0.034632,"preClose":148.85,"low":153.48,"week52Low":32.55,"pbRate":"--","week52High":198.18,"institutionHeld":0,"latestPrice":156.24,"eps":0,"divideRate":0.008574,"volume":570413,"delay":0,"ttmEps":0,"open":153.69,"prevYearClose":159.39,"prevWeekClose":148.85,"prevMonthClose":172.7,"prevQuarterClose":159.39,"fiveDayClose":169.89,"twentyDayClose":156.45,"sixtyDayClose":160.2},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/LABU\",params:#limit:5,,,undefined,":[{"date":"2025-09-23","symbol":"LABU","amount":0.10273,"announcedDate":"2025-09-22","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-09-23","defaultRemindTime":1758634200000,"name":"三倍做多标普生物-Direxion","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-09-30","payableDate":"2025-09-23","currency":"USD","dateTimestamp":1758600000000,"payDate":"2025-09-30"},{"date":"2025-06-24","symbol":"LABU","amount":0.21897,"announcedDate":"2025-06-23","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-06-24","defaultRemindTime":1750771800000,"name":"三倍做多标普生物-Direxion","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-07-01","payableDate":"2025-06-24","currency":"USD","dateTimestamp":1750737600000,"payDate":"2025-07-01"},{"date":"2025-03-25","symbol":"LABU","amount":0.10714,"announcedDate":"2025-03-24","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-03-25","defaultRemindTime":1742909400000,"name":"三倍做多标普生物-Direxion","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-04-01","payableDate":"2025-03-25","currency":"USD","dateTimestamp":1742875200000,"payDate":"2025-04-01"},{"date":"2024-06-25","symbol":"LABU","amount":0.15021,"announcedDate":null,"type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2024-06-25","defaultRemindTime":1719322200000,"name":"三倍做多标普生物-Direxion","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2024-07-02","payableDate":"2024-06-25","currency":"USD","dateTimestamp":1719288000000,"payDate":"2024-07-02"},{"date":"2024-03-19","symbol":"LABU","amount":0.16064,"announcedDate":"2024-03-18","type":"dividend","market":"US","newRecordDate":"2024-03-20","defaultRemindTime":1710855000000,"name":"三倍做多标普生物-Direxion","recordDate":"2024-03-26","payableDate":"2024-03-20","currency":"USD","dateTimestamp":1710820800000,"payDate":"2024-03-26"}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"LABU\",market:\"US\",,,undefined,":[{"executeDate":"2018-06-19","recordDate":"2018-06-20","paymentDate":"2018-06-26","value":0.01932,"currency":"USD"},{"executeDate":"2018-09-25","recordDate":"2018-09-26","paymentDate":"2018-10-02","value":0.0954,"currency":"USD"},{"executeDate":"2018-12-27","recordDate":"2018-12-28","paymentDate":"2019-01-04","value":0.09621,"currency":"USD"},{"executeDate":"2019-03-19","recordDate":"2019-03-20","paymentDate":"2019-03-26","value":0.10973,"currency":"USD"},{"executeDate":"2019-06-25","recordDate":"2019-06-26","paymentDate":"2019-07-02","value":0.03745,"currency":"USD"}],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"LABU\",market:\"US\",delay:false,,,undefined,":{},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"LABU\",pageSize:20,pageCount:7,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2618792490","title":"Exclusive: AI's Next Boom? Health Care And Space, Says Fusion Fund's Lu Zhang","url":"https://stock-news.laohu8.com/highlight/detail?id=2618792490","media":"Benzinga_recent_news","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2618792490?lang=en_us&edition=fundamental","pubTime":"2026-03-12 00:10","pubTimestamp":1773245400,"startTime":"0","endTime":"0","summary":"Lu Zhang, founder of venture capital firm Fusion Fund, says AI companies focused on health care and space are poised for growth this year.","market":"sh","thumbnail":"https://cdn.benzinga.com/files/images/story/2026/03/11/Exclusive-AIs-Next-Boom--Healthcare-And-.png?optimize=medium&dpr=2&auto=webp&width=240","type":0,"news_type":0,"thumbnails":["https://cdn.benzinga.com/files/images/story/2026/03/11/Exclusive-AIs-Next-Boom--Healthcare-And-.png?optimize=medium&dpr=2&auto=webp&width=240"],"rights":{"source":"benzinga_recent_news","url":"https://www.benzinga.com/markets/private-markets/26/03/51192180/exclusive-ais-next-boom-health-care-and-space-says-fusion-funds-lu-zhang","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.benzinga.com/markets/private-markets/26/03/51192180/exclusive-ais-next-boom-health-care-and-space-says-fusion-funds-lu-zhang","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"benzinga_recent_news","symbols":["LU0289739343.SGD","XLV","SG9999001424.SGD","IE00BKVL7J92.USD","LU0094547139.USD","IE0034235295.USD","LU0057025933.USD","LU0234572021.USD","AIYY","LU0528227936.USD","LU2417539215.USD","MSFU","LU2458330243.SGD","MSFO","LU2750360641.GBP","UFO","LU2746668974.SGD","LU0823417653.USD","MSFX","LU1989764664.SGD","LU1236620834.HKD","LU0170899867.USD","LU1803068979.SGD","LABU","MSFY","LU2168564222.USD","LU2360032135.SGD","LU1116320737.USD","LU0238689110.USD","LU0314106906.USD","LU0072462426.USD","LU2360106780.USD","MSFW","XBI","MSFD","LU0106261372.USD","LU1244550494.USD","LU1232071149.USD","IE000W1ABFV2.USD","LU0545039389.USD","LU2552382215.SGD","LU0109392836.USD","LU0353189680.USD","LU0965509101.SGD","VGT","LU2089284900.SGD","MSFT","AI","MSFL","ARKX"],"gpt_icon":1},{"id":"2618929895","title":"Sagimet: Undervalued MASH and Acne Pipeline with Best-in-Class Combination Potential Supports Buy Rating","url":"https://stock-news.laohu8.com/highlight/detail?id=2618929895","media":"TIPRANKS","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2618929895?lang=en_us&edition=fundamental","pubTime":"2026-03-11 23:15","pubTimestamp":1773242133,"startTime":"0","endTime":"0","summary":"Sagimet Biosciences, Inc. Class A, the Healthcare sector company, was revisited by a Wall Street analyst today. Analyst Brandon Folkes from H.C. Wa...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/ratings/sagimet-undervalued-mash-and-acne-pipeline-with-best-in-class-combination-potential-supports-buy-rating-ratings-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/ratings/sagimet-undervalued-mash-and-acne-pipeline-with-best-in-class-combination-potential-supports-buy-rating-ratings-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["XBI","LABU","BK4585","BK4581","XLV","BK4588","SGMT","BK4139"],"gpt_icon":0},{"id":"2618928953","title":"IotaMotion Strengthens Leadership Position in Robotic Cochlear Implant Surgery with Issuance of New U.S. Patent","url":"https://stock-news.laohu8.com/highlight/detail?id=2618928953","media":"prnewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2618928953?lang=en_us&edition=fundamental","pubTime":"2026-03-11 21:38","pubTimestamp":1773236280,"startTime":"0","endTime":"0","summary":"ST. PAUL, Minn., March 11, 2026 /PRNewswire/ -- iotaMotion, Inc., the leader in robotic-assisted insertion systems for cochlear implantation and creator of iotaSOFT, the first and only FDA cleared robotic-assisted cochlear implant insertion system, today announced the issuance of U.S. Patent No. 12,558,123, further strengthening its intellectual property portfolio in robotic-assisted cochlear implantation.The iotaSOFT Robotic-Assisted Cochlear Implant Insertion System enables slow, consistent and controlled electrode insertion to preserve delicate intracochlear structures. FDA cleared for patients four years and older, the system addresses a major unmet need, as fewer than 5% of the 60 million people worldwide who could benefit from cochlear implants receive them.iotaMotion— the leader in robotic-assisted insertion systems for cochlear implantation and maker of the iotaSOFT Insertion System, the first and only FDA market authorized robotic-assisted insertion system, indicated for patie","market":"sg","thumbnail":"https://mma.prnewswire.com/media/2931111/IOTAMOTION_INC__Robotic_Assisted_Cochlear_Implant_Insertion_System.jpg?w=300","type":0,"news_type":0,"thumbnails":["https://mma.prnewswire.com/media/2931111/IOTAMOTION_INC__Robotic_Assisted_Cochlear_Implant_Insertion_System.jpg?w=300"],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.prnewswire.com/apac/news-releases/iotamotion-strengthens-leadership-position-in-robotic-cochlear-implant-surgery-with-issuance-of-new-us-patent-302710523.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LABU","BK7007","COH.AU"],"gpt_icon":0},{"id":"2618928105","title":"Jefferies Remains a Buy on Regeneron (REGN)","url":"https://stock-news.laohu8.com/highlight/detail?id=2618928105","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2618928105?lang=en_us&edition=fundamental","pubTime":"2026-03-11 21:30","pubTimestamp":1773235800,"startTime":"0","endTime":"0","summary":"Jefferies analyst Akash Tewari maintained a Buy rating on Regeneron today and set a price target of $890.00. Tewari covers the Healthcare sector, f...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/jefferies-remains-a-buy-on-regeneron-regn-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/jefferies-remains-a-buy-on-regeneron-regn-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LU2362541273.HKD","XBI","LU0320765992.SGD","LU0823434740.USD","BK4139","LU2089984988.USD","XLV","LU0109394709.USD","LABU","BK4581","LU0823416689.USD","LU2237438978.USD","LU2362541513.USD","LU0289739699.SGD","BK4588","BK4585","LU2023250504.SGD","REGN","LU0889565916.HKD","LU2106854487.HKD","LU1974910355.USD","LU2468319806.SGD","LU0058720904.USD","LU0823434583.USD","LU0053666078.USD","LU0882574055.USD","LU0114720955.EUR","LU1917777945.USD","LU2362540622.SGD"],"gpt_icon":0},{"id":"2618281719","title":"Evercore ISI Remains a Buy on BioNTech SE (BNTX)","url":"https://stock-news.laohu8.com/highlight/detail?id=2618281719","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2618281719?lang=en_us&edition=fundamental","pubTime":"2026-03-11 21:29","pubTimestamp":1773235740,"startTime":"0","endTime":"0","summary":"Evercore ISI analyst Cory Kasimov maintained a Buy rating on BioNTech SE today and set a price target of $130.00. Kasimov covers the Healthcare sec...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/evercore-isi-remains-a-buy-on-biontech-se-bntx-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/evercore-isi-remains-a-buy-on-biontech-se-bntx-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LU0823039010.USD","BNTX","LU2152927971.USD","LU0345775950.USD","LU2125910849.SGD","LU0499858438.USD","SGXZ58947870.SGD","SG9999005177.SGD","BK4551","LU2177674079.SGD","LU0979878070.USD","LU0823038988.USD","BK4548","LU0261945553.USD","LU2065170008.USD","LU0516422440.USD","LU1861217088.USD","LU0441851309.USD","BK4535","SG9999002406.SGD","SG9999002604.SGD","SG9999001135.SGD","LU1861220207.SGD","LABU","LU0251143029.SGD","LU0589944569.HKD","BK4554","BK4220","LU1242518857.USD","LU2065171311.SGD","LU2238330802.EUR","IE0001KFT4U8.USD","LU0048573645.USD","SG9999013478.USD","LU1839390173.USD","LU0175139822.USD","LU2045819591.USD","BK4085","LU0345776255.USD","LU1048588211.SGD","XLV","LU0516423091.SGD","SG9999002679.SGD","LU1242518931.SGD","BK4139","LU1770036033.HKD","LU2125910500.SGD","XBI","SG9999013460.SGD"],"gpt_icon":0},{"id":"2618928106","title":"Jefferies Remains a Buy on Oruka Therapeutics (ORKA)","url":"https://stock-news.laohu8.com/highlight/detail?id=2618928106","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2618928106?lang=en_us&edition=fundamental","pubTime":"2026-03-11 21:28","pubTimestamp":1773235719,"startTime":"0","endTime":"0","summary":"Jefferies analyst Roger Song maintained a Buy rating on Oruka Therapeutics today and set a price target of $45.00. Song covers the Healthcare secto...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/jefferies-remains-a-buy-on-oruka-therapeutics-orka-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/jefferies-remains-a-buy-on-oruka-therapeutics-orka-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4139","XLV","XBI","ORKA","LABU","BK4581","BK4588","BK4585"],"gpt_icon":0},{"id":"2618940706","title":"Clearmind advances recruitment for CMND-100 trial’s third cohort","url":"https://stock-news.laohu8.com/highlight/detail?id=2618940706","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2618940706?lang=en_us&edition=fundamental","pubTime":"2026-03-11 21:10","pubTimestamp":1773234638,"startTime":"0","endTime":"0","summary":"Clearmind Medicine (CMND) announced the continuation of participant enrollment for the third cohort of its ongoing FDA-approved Phase I/IIa clinica...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/clearmind-advances-recruitment-for-cmnd-100-trials-third-cohort-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/clearmind-advances-recruitment-for-cmnd-100-trials-third-cohort-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4585","BK4588","CMND","BK4007","LABU"],"gpt_icon":0},{"id":"2618775940","title":"Analysts Offer Insights on Healthcare Companies: Legend Biotech (LEGN) and Medtronic (MDT)","url":"https://stock-news.laohu8.com/highlight/detail?id=2618775940","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2618775940?lang=en_us&edition=fundamental","pubTime":"2026-03-11 21:10","pubTimestamp":1773234604,"startTime":"0","endTime":"0","summary":"Companies in the Healthcare sector have received a lot of coverage today as analysts weigh in on Legend Biotech (LEGN – Research Report) and Medtro...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-legend-biotech-legn-and-medtronic-mdt-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-legend-biotech-legn-and-medtronic-mdt-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["IE00BVYPNV92.GBP","LU0128526141.USD","IE00BQXX3C00.GBP","LU0314106906.USD","LU1116320901.HKD","IE00B3PB1722.GBP","LU2112291526.USD","BK4505","LU2089284900.SGD","LU1506573853.SGD","XBI","LU1023059063.AUD","LU1116320737.USD","XLV","LU0029874061.USD","LU1571399168.USD","LU1057294990.SGD","LU2028103732.USD","LU0070302665.USD","LU0976567544.SGD","LU0158827781.USD","LU0211326839.USD","LU1989764664.SGD","LU0265550946.USD","BK4139","BK4566","LU2468319806.SGD","IE000M9KFDE8.USD","LU0122379950.USD","LU0432979614.USD","BK4137","BK4082","BK4585","LU0496365809.HKD","IE00BQXX3D17.EUR","IE00BVYPNW00.USD","LU0208291251.USD","LU1989771016.USD","LU1244550494.USD","LU1061106388.HKD","LU1291159041.SGD","HCSG","IE00BDGV0183.EUR","LU2271345857.HKD","LEGN","MDT","LU2089984988.USD","LU0072461881.USD","LU0320765489.SGD","LABU"],"gpt_icon":0},{"id":"2618400909","title":"New Study Shows Adherence to Monthly Injectable Buprenorphine Linked to Lower Healthcare Utilization and Costs in Opioid Use Disorder","url":"https://stock-news.laohu8.com/highlight/detail?id=2618400909","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2618400909?lang=en_us&edition=fundamental","pubTime":"2026-03-11 21:00","pubTimestamp":1773234000,"startTime":"0","endTime":"0","summary":"Patients adherent to SUBLOCADE for 12 months had 42% lower adjusted non-MOUD medical costs vs. those adherent to other forms of MOUDPatients adherent to SUBLOCADE had the lowest inpatient, emergency d","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/03/11/3253803/0/en/New-Study-Shows-Adherence-to-Monthly-Injectable-Buprenorphine-Linked-to-Lower-Healthcare-Utilization-and-Costs-in-Opioid-Use-Disorder.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4585","LU0029874061.USD","LU0128526141.USD","BK4581","HCSG","BK4137","BK4588","XBI","LABU","XLV"],"gpt_icon":0},{"id":"2618994763","title":"Aster DM Healthcare’s creditors clear key vote on amalgamation plan","url":"https://stock-news.laohu8.com/highlight/detail?id=2618994763","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2618994763?lang=en_us&edition=fundamental","pubTime":"2026-03-11 20:41","pubTimestamp":1773232868,"startTime":"0","endTime":"0","summary":"An update from Aster DM Healthcare Ltd. ( ($IN:ASTERDM) ) is now available. Aster DM Healthcare said its unsecured trade creditors have approved a ...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/aster-dm-healthcares-creditors-clear-key-vote-on-amalgamation-plan?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/aster-dm-healthcares-creditors-clear-key-vote-on-amalgamation-plan?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LU0128526141.USD","LU0029874061.USD","XBI","BK4588","XLV","BK4161","LABU","BK4546","BK4581","HCSG","BK4137","DM","BK4585"],"gpt_icon":0},{"id":"2618942482","title":"Sonida Senior Living Closes Transformative CNL Healthcare Acquisition","url":"https://stock-news.laohu8.com/highlight/detail?id=2618942482","media":"TIPRANKS","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2618942482?lang=en_us&edition=fundamental","pubTime":"2026-03-11 20:18","pubTimestamp":1773231505,"startTime":"0","endTime":"0","summary":"The latest update is out from Sonida Senior Living ( ($SNDA) ). On March 11, 2026, Sonida Senior Living reported its fourth-quarter and full-year 2...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/sonida-senior-living-closes-transformative-cnl-healthcare-acquisition?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/sonida-senior-living-closes-transformative-cnl-healthcare-acquisition?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["HCSG","BK4168","BK4581","CNL","XBI","BK4137","LABU","LU0029874061.USD","XLV","BK4588","LU0128526141.USD","BK4585"],"gpt_icon":0},{"id":"2618942107","title":"Scotiabank Remains a Buy on American Healthcare REIT, Inc. (AHR)","url":"https://stock-news.laohu8.com/highlight/detail?id=2618942107","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2618942107?lang=en_us&edition=fundamental","pubTime":"2026-03-11 20:17","pubTimestamp":1773231424,"startTime":"0","endTime":"0","summary":"In a report released today, Nicholas Yulico from Scotiabank maintained a Buy rating on American Healthcare REIT, Inc., with a price target of $59.0...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/scotiabank-remains-a-buy-on-american-healthcare-reit-inc-ahr-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/scotiabank-remains-a-buy-on-american-healthcare-reit-inc-ahr-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4581","XBI","BK4588","XLV","BK4225","AHR","LABU","REIT","BK4585"],"gpt_icon":0},{"id":"2618942100","title":"Fidia Completes Bond Conversion, Expands Share Capital and Free Float","url":"https://stock-news.laohu8.com/highlight/detail?id=2618942100","media":"TIPRANKS","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2618942100?lang=en_us&edition=fundamental","pubTime":"2026-03-11 20:16","pubTimestamp":1773231397,"startTime":"0","endTime":"0","summary":"The latest announcement is out from Fidia Spa ( ($IT:FDA) ). Fidia S.p.A., a Turin‑based provider of advanced numerical controls, high‑speed millin...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/fidia-completes-bond-conversion-expands-share-capital-and-free-float?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/fidia-completes-bond-conversion-expands-share-capital-and-free-float?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LABU","US30Y.BOND","US6M.BOND","BK4588","US3Y.BOND","TLTW","TMF","BK4585","US10Y.BOND","US12M.BOND","US2Y.BOND","VGT","US5Y.BOND","US7Y.BOND"],"gpt_icon":0},{"id":"2618594296","title":"SCIENTURE Broadens Commercial Access for REZENOPY™, Highest-Dose FDA-Approved Naloxone Nasal Spray, Through GPO Agreements Reaching Over 5,000 U.S. Institutions","url":"https://stock-news.laohu8.com/highlight/detail?id=2618594296","media":"GlobeNewswire","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2618594296?lang=en_us&edition=fundamental","pubTime":"2026-03-11 20:05","pubTimestamp":1773230700,"startTime":"0","endTime":"0","summary":"Expands institutional footprint with potential penetration of more than ~ 60% of the U.S. market, while expanding reach across EMS providers and rehabilitation centers U.S. naloxone market totals $141","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/03/11/3253734/0/en/SCIENTURE-Broadens-Commercial-Access-for-REZENOPY-Highest-Dose-FDA-Approved-Naloxone-Nasal-Spray-Through-GPO-Agreements-Reaching-Over-5-000-U-S-Institutions.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["SCNX","BK4167","LABU","BK4585","BK4588"],"gpt_icon":0},{"id":"1165877473","title":"Huadong Medicine's Investigational Drug HDM2024 Receives FDA Clearance for US Clinical Trial","url":"https://stock-news.laohu8.com/highlight/detail?id=1165877473","media":"Stock News","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1165877473?lang=en_us&edition=fundamental","pubTime":"2026-03-11 19:46","pubTimestamp":1773229589,"startTime":"0","endTime":"0","summary":"Huadong Medicine Co., Ltd. (000963.SZ) announced that on March 10, 2026, its wholly-owned subsidiary, Hangzhou Zhongmei Huadong Pharmaceutical Co., Ltd., received notification from the U.S. Food and...","market":"sg","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK0196","BK4585","BK0183","000963","BK0175","BK0132","BK0188","BK4588","LU2328871848.SGD","LU1969619763.USD","BK0209","LABU","BK0187"],"gpt_icon":0},{"id":"2618941379","title":"Analysts Have Conflicting Sentiments on These Healthcare Companies: Atricure (ATRC), Q32 Bio (QTTB) and Shoulder Innovations, Inc. (SI)","url":"https://stock-news.laohu8.com/highlight/detail?id=2618941379","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2618941379?lang=en_us&edition=fundamental","pubTime":"2026-03-11 19:20","pubTimestamp":1773228006,"startTime":"0","endTime":"0","summary":"Companies in the Healthcare sector have received a lot of coverage today as analysts weigh in on Atricure (ATRC – Research Report), Q32 Bio (QTTB –...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-have-conflicting-sentiments-on-these-healthcare-companies-atricure-atrc-q32-bio-qttb-and-shoulder-innovations-inc-si-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-have-conflicting-sentiments-on-these-healthcare-companies-atricure-atrc-q32-bio-qttb-and-shoulder-innovations-inc-si-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["HCSG","BK4585","LU0128526141.USD","XBI","BK4581","BK4211","LU0029874061.USD","BK4588","SI","BK4137","ATRC","LABU","BK4082","XLV","BK4139","QTTB"],"gpt_icon":0},{"id":"2618294136","title":"Analysts Conflicted on These Healthcare Names: MoonLake Immunotherapeutics (MLTX), Sarepta Therapeutics (SRPT) and vTv Therapeutics (VTVT)","url":"https://stock-news.laohu8.com/highlight/detail?id=2618294136","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2618294136?lang=en_us&edition=fundamental","pubTime":"2026-03-11 19:11","pubTimestamp":1773227469,"startTime":"0","endTime":"0","summary":"Analysts have been eager to weigh in on the Healthcare sector with new ratings on MoonLake Immunotherapeutics (MLTX – Research Report), Sarepta The...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-conflicted-on-these-healthcare-names-moonlake-immunotherapeutics-mltx-sarepta-therapeutics-srpt-and-vtv-therapeutics-vtvt-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-conflicted-on-these-healthcare-names-moonlake-immunotherapeutics-mltx-sarepta-therapeutics-srpt-and-vtv-therapeutics-vtvt-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4139","IE0002141913.USD","LU0128526141.USD","IE00BJJMRZ35.SGD","SRPT","IE00BFTCPJ56.SGD","IE00B2B36J28.USD","XBI","SRPU","VTVT","MLTX","BK4581","BK4588","HCSG","LU0029874061.USD","BK4137","LABU","BK4585","IE00BJT1NW94.SGD","IE0009355771.USD","XLV"],"gpt_icon":0},{"id":"2618949521","title":"Analysts’ Opinions Are Mixed on These Healthcare Stocks: Kairos Pharma, Ltd. (KAPA), Pfizer (PFE) and Medtronic (MDT)","url":"https://stock-news.laohu8.com/highlight/detail?id=2618949521","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2618949521?lang=en_us&edition=fundamental","pubTime":"2026-03-11 19:00","pubTimestamp":1773226813,"startTime":"0","endTime":"0","summary":"Analysts have been eager to weigh in on the Healthcare sector with new ratings on Kairos Pharma, Ltd. (KAPA – Research Report), Pfizer (PFE – Resea...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-opinions-are-mixed-on-these-healthcare-stocks-kairos-pharma-ltd-kapa-pfizer-pfe-and-medtronic-mdt-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-opinions-are-mixed-on-these-healthcare-stocks-kairos-pharma-ltd-kapa-pfizer-pfe-and-medtronic-mdt-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LU0320765489.SGD","LU1244550221.USD","LU2028103732.USD","IE00BQXX3C00.GBP","LU0321505439.SGD","IE00BLSP4239.USD","LU1983299246.USD","BK4585","LU0158827948.USD","SG9999001176.USD","BK4139","IE00B42XCP33.USD","LU1989771016.USD","LU1061106388.HKD","IE0002270589.USD","LU1116320901.HKD","BK4137","LU0306806265.USD","LU1291159041.SGD","LU0225284248.USD","LU0122379950.USD","LU1883839398.USD","LU0234572021.USD","IE00BQXX3D17.EUR","LU0058720904.USD","IE00B3T34201.USD","LU0208291251.USD","LU2468319806.SGD","SG9999003800.SGD","LU0211331839.USD","LU1244550577.SGD","LU1894683348.USD","PFE","IE00B3PB1722.GBP","LU2089284900.SGD","BK4082","IE00BVYPNW00.USD","LU0306807586.USD","BK4566","BK4534","LU1057294990.SGD","LU0265550359.USD","IE00BQXX3F31.USD","LU0496365809.HKD","LU1066053197.SGD","SG9999002224.SGD","LU1023059063.AUD","IE00BDGV0183.EUR","LU0265550946.USD","SG9999001176.SGD","LU1506573853.SGD","LU1894683264.USD","SG9999013999.USD","LU1066051498.USD","IE00BGHQF631.EUR","LU0170899867.USD","LU2089283258.USD","IE00B19Z3581.USD","LU0211326755.USD","LU0432979614.USD","BK4550","BK4592","LU0070302665.USD","IE00BFXG1179.USD","LU0314106906.USD","LU0128526141.USD","LU2112291526.USD","MDT","LU0976567544.SGD","SG9999011175.SGD","LU1116320737.USD","LU0072461881.USD","IE00BVYPNV92.GBP","XBI","LU0158827781.USD","IE00B19Z3B42.SGD","BK4588","LU0985481810.HKD","LU2089984988.USD","BK4533","LABU","IE00BBT3K403.USD","BK4007","IE00BLSP4452.SGD","SGXZ57979304.SGD","BK4568","LU0868494617.USD","LU0029874061.USD","IE000M9KFDE8.USD","LU0289739699.SGD","LU0162691827.USD","LU0456855351.SGD","LU0225771236.USD","LU2111349929.HKD","LU0211326839.USD","LU1571399168.USD","BK4581","LU1989764748.USD","LU2023251221.USD","SG9999002232.USD","LU1989764664.SGD","LU2271345857.HKD","BK4599","LU0321505868.SGD","KAPA","LU1244550494.USD"],"gpt_icon":0},{"id":"2618949566","title":"Canaccord Genuity Reaffirms Their Buy Rating on BioNTech SE (BNTX)","url":"https://stock-news.laohu8.com/highlight/detail?id=2618949566","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2618949566?lang=en_us&edition=fundamental","pubTime":"2026-03-11 18:57","pubTimestamp":1773226621,"startTime":"0","endTime":"0","summary":"Canaccord Genuity analyst John Newman maintained a Buy rating on BioNTech SE today and set a price target of $171.00. Newman covers the Healthcare ...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/canaccord-genuity-reaffirms-their-buy-rating-on-biontech-se-bntx-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/canaccord-genuity-reaffirms-their-buy-rating-on-biontech-se-bntx-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LU0261945553.USD","SG9999002620.SGD","BK4548","LU1242518931.SGD","LU1242518857.USD","IE00BD6J9T35.USD","LU0516422366.SGD","SG9999002414.USD","XBI","LU0345776255.USD","LU0823038988.USD","SGXZ58947870.SGD","LU0072462343.USD","LU0210637038.USD","LU0823039010.USD","LU0572939691.SGD","BK4568","LU0441851309.USD","LU0048573645.USD","LU0348788117.USD","LU2065169927.USD","BK4554","LU1861217088.USD","BK4503","SG9999014484.SGD","LU2125910849.SGD","SG9999005177.SGD","LU0532188223.SGD","SG9999002406.SGD","SG9999004360.SGD","LU0345775950.USD","LU2125910500.SGD","SG9999013486.USD","BK4588","SG9999001135.SGD","LU0516422440.USD","LU0499858602.USD","LU2065171402.SGD","LU0289960550.SGD","BK4220","LU2065170008.USD","BK4585","LU0516423091.SGD","LU1839390173.USD","LU1861220207.SGD","LU0572940350.SGD","LU2008162690.USD","LU2177674079.SGD","SG9999013478.USD","BK4535","SG9999002604.SGD","BNTX","LU2238330802.EUR","BK4139","SG9999013460.SGD","LU2045819591.USD","BK4085","LU0516423174.USD","BK4551","IE0001KFT4U8.USD","BK4566","SG9999002679.SGD","LU0979878070.USD","LU2065171311.SGD","LU0264606111.USD","LABU","IE0034224299.USD","SG9999014492.USD","BK4581","LU1770036033.HKD","LU0737861269.HKD","LU0499858438.USD","SG9999006266.SGD","LU0251143029.SGD","LU0589944569.HKD","LU0516422952.EUR","LU0175139822.USD","IE0031814969.USD","LU1048588211.SGD","LU2152927971.USD","LU2543165471.USD","LU2360107671.USD"],"gpt_icon":0},{"id":"2618495719","title":"Analysts’ Opinions Are Mixed on These Healthcare Stocks: Evotec AG (EVO), Shoulder Innovations, Inc. (SI) and Bausch + Lomb Corporation (BLCO)","url":"https://stock-news.laohu8.com/highlight/detail?id=2618495719","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2618495719?lang=en_us&edition=fundamental","pubTime":"2026-03-11 18:51","pubTimestamp":1773226278,"startTime":"0","endTime":"0","summary":"Companies in the Healthcare sector have received a lot of coverage today as analysts weigh in on Evotec AG (EVO – Research Report), Shoulder Innova...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-opinions-are-mixed-on-these-healthcare-stocks-evotec-ag-evo-shoulder-innovations-inc-si-and-bausch-lomb-corporation-blco-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-opinions-are-mixed-on-these-healthcare-stocks-evotec-ag-evo-shoulder-innovations-inc-si-and-bausch-lomb-corporation-blco-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4588","XLV","BK4121","LU0128526141.USD","BK4082","BK4137","XBI","BK4211","BK4198","BK4585","EVO","LABU","BK4210","LU0029874061.USD","SI","BK4581","AG","BLCO","HCSG"],"gpt_icon":0}],"pageSize":20,"totalPage":21,"pageCount":7,"totalSize":417,"code":"91000000","status":"200"}]}}